bicalutamide and aq4n
bicalutamide has been researched along with aq4n in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Byrne, NM; Camac, SN; McKeown, SR; Ming, L; Mitchell, CA; Ward, C; Waugh, DJ; Worthington, J | 1 |
Other Studies
1 other study(ies) available for bicalutamide and aq4n
| Article | Year |
|---|---|
Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response.
Topics: Androgen Antagonists; Anilides; Animals; Anthraquinones; Cell Hypoxia; Cell Line, Tumor; Gene Expression Profiling; Humans; Male; Mice; Mice, Inbred BALB C; Nitriles; Prostatic Neoplasms; Signal Transduction; Time Factors; Tosyl Compounds | 2013 |